Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Roche Diagnostics Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (187)
Cancellation by sponsor (59)
COVID-19 test kit (5)

Date

2026 (16)
2025 (11)
2024 (26)
2023 (23)
2022 (13)
2021 (8)
2020 (17)
2019 (11)
2018 (38)
2017 (19)
2016 (4)
2015 (5)
2014 (7)
2013 (11)
2012 (14)
2011 (10)
2010 (18)

Search

Sponsor content

251 result(s) found, displaying 81 to 90

Roche Diagnostics Australia Pty Limited - Acquired genetic alteration IVDs Cancelled under Section 41GL(d) of the Act

26 May 2023

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Acquired genetic alteration IVDs Cancelled under Section 41GL(d) of the Act

26 May 2023

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Cobas® Liat® SARS-CoV-2

28 April 2023

COVID-19 test kit

Nucleic Acid Test - Intended for use: Point-of-care test
Roche Diagnostics Australia Pty Limited - Clinical chemistry substrate IVDs Cancelled under Section 41GL(d) of the Act

30 March 2023

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

30 March 2023

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Interpretive software IVDs (368050)

3 June 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Roche Diagnostics Australia Pty Limited - Interpretive software IVDs.
Roche Diagnostics Australia Pty Limited - Clinical chemistry substrate IVDs (366676)

19 May 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Roche Diagnostics Australia Pty Limited - Clinical chemistry substrate IVDs.
Roche Diagnostics Australia Pty Limited - Interpretive software IVDs (354882)

12 February 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Roche Diagnostics Australia Pty Limited - Interpretive software IVDs.
Roche Diagnostics Australia Pty Limited - Clinical chemistry-specific protein IVDs Cancelled under Section 41GL(d) of the Act

28 September 2022

Cancellation by sponsor

Requested by Roche Diagnostics Australia Pty Limited
Roche Diagnostics Australia Pty Limited - Interpretive software IVDs (346581)

26 October 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Roche Diagnostics Australia Pty Limited - Interpretive software IVDs.

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.